Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Everyone but Capt. Francesco Schettino maybe.
I agree with you and unless this stock has a really huge bounce, I'm looking at about a 2 to 3 year investment here for me.
I've talked with a couple of people today that think the stock is doing good because it's back up 22% and it's almost recovered what it lost yesterday @ 100%. I think they must not understand basic math. If a stock is $1 and drops 10% it's a loss of .10 to close @ .90 then if it's back up 10% the next day that is .09 gain to close @ .99, they don't understand percentages at all and I didn't want to make them sound stupid for what they were saying by correcting them. Although any gain this stock does is a blessing to me I bought @.008 and .0105 and have 860k shares that I'll just have to ride out and hope for the best.
Set forth below is certain financial information from our unaudited financial statements as at and for the year ended December 31, 2012. The Company’s cash balance at December 31, 2012 and anticipated cash flow from operating activities are not sufficient to satisfy its current liabilities and meet its exploration commitments of $12.1 million and $21.9 million, over the twelve months ending December 31, 2013 and the twenty-four months ending December 31, 2014, respectively. As at December 31, 2012 the Company has $0.8 million of cash and cash equivalents, of which $0.1 million is committed to carry out activities of the Myra and Sara joint venture. The residual cash of $0.7 million is available for general operations of the Company and to meet its current liabilities and exploration commitments of $12.1 million and $21.9 million as described above. To meet its obligations, the Company must divest certain oil and gas interests, subsidiaries or other available assets, including entering into other financing arrangements typical in the industry such as farming out interests in oil and natural gas properties. The Company will also continue to seek to raise capital through equity and debt markets. The Company’s cash as at December 31, 2012, available for general operations of $0.7 million is not sufficient to meet its ongoing operational requirements. In the fourth quarter of 2012, the company has curtailed staffing at its Canadian and Indian offices and rationalized other expenditures to minimize the ongoing operational requirements pending the outcome.
Oil and gas sales 487,467
Interest Income 14,319
Impairment of oil and gas properties 15,861,223
Net loss and comprehensive loss 21,812,552
Net loss per share – basic and diluted 0.17
Current assets 22,336,143
Property and equipment 42,256,456
Total assets 67,503,267
Current liabilities 41,417,139
Total liabilities 42,251,973
Stockholders’ equity 25,251,294
Cash dividends 0
I hope this stock picks up speed, I lost 50% and 20% on two oil stocks today.
So who's buying, there was a 13 mil buy @ 3:30 for .0021 and a 6 mil buy @ 3:45 for .0019. The only real big sale off was for 4 mil @ 3:50 for .0020, this is according to E-trades charts. Someone must see daylight to be buying this stock.
Today's news.
GeoGlobal Resources Inc. ("GeoGlobal" or the "Company") (NYSE MKT: GGR) today announced that the Company has not filed with the US and Canadian Regulatory authorities its audited consolidated financial statements for the year ended December 31, 2012, that were due to be filed on April 16, 2013. The Company did not have sufficient funding to file its audited financial statements by the due date. As previously announced, the Company and Sarus Energy Ltd. ("Sarus") had agreed to close the first part of the sale of certain of the Company's Indian assets (the "Indian Asset Sale") for proceeds to the Company of $2 million on April 12, 2013. Sarus did not close the first part of the transaction on time and has requested an extension. The Company continues to focus on closing the transaction with Sarus and on finding other sources of capital. There is a substantial risk it will not prove to be successful.
The Company anticipates filing its audited financial statements upon the closing and funding of the first part of Indian Asset Sale or upon obtaining funding from other sources.
Financial Review
Set forth below is certain financial information from our unaudited financial statements as at and for the year ended December 31, 2012. All amounts in the release are in U.S. dollars unless otherwise noted:
View data
Oil and gas sales 487,467 Interest Income 14,319 Impairment of oil and gas properties 15,861,223 Net loss and comprehensive loss 21,812,552 Net loss per share - basic and diluted 0.17 Current assets 22,336,143 Property and equipment 42,256,456 Total assets 67,503,267 Current liabilities 41,417,139 Total liabilities 42,251,973 Stockholders' equity 25,251,294 Cash dividends -0-
Going Concern
The Company has not achieved its planned principal operations and is considered to be in the development stage. The Company's exploration activities and overhead expenses are financed by way of equity issuance and to-date, oil and gas sales are incidental to the exploration process.
The Company's financial statements as at and for the year ended December 31, 2012 have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. During the year ended December 31, 2012, the Company incurred a net loss of approximately $21.8 million, used approximately $1.8 million of cash flow in its operating activities, used approximately $9.7 million in its investing activities and had an accumulated deficit of approximately $82.0 million. As at December 31, 2012, the Company has working capital deficiency of approximately $19.1 million. These matters raise substantial doubt about the Company's ability to continue as a going concern.
The Company's cash balance at December 31, 2012 and anticipated cash flow from operating activities are not sufficient to satisfy its current liabilities and meet its exploration commitments of $12.1 million and $21.9 million, over the twelve months ending December 31, 2013 and the twenty-four months ending December 31, 2014, respectively. As at December 31, 2012 the Company has $0.8 million of cash and cash equivalents, of which $0.1 million is committed to carry out activities of the Myra and Sara joint venture. The residual cash of $0.7 million is available for general operations of the Company and to meet its current liabilities and exploration commitments of $12.1 million and $21.9 million as described above.
To meet its obligations, the Company must divest certain oil and gas interests, subsidiaries or other available assets, including entering into other financing arrangements typical in the industry such as farming out interests in oil and natural gas properties. The Company will also continue to seek to raise capital through equity and debt markets.
The Company's cash as at December 31, 2012, available for general operations of $0.7 million is not sufficient to meet its ongoing operational requirements. In the fourth quarter of 2012, the Company has curtailed staffing at its Canadian and Indian offices and rationalized other expenditures to minimize the ongoing operational requirements pending the outcome of uncommitted financing activities described above. If these activities are unsuccessful, the Company will be forced to substantially curtail or cease exploration, appraisal and development expenditures and other operating activities.
The Company's ability to continue as a going concern is dependent on the success of the operational and financing initiatives and the successful completion of further exploration and development activities that will generate profitable operations from its oil and natural gas interests in the future. The Company must make an assessment of its ability to fulfill current liabilities and to meet future exploration requirements in the normal course of business. The assessment requires estimates regarding future uncommitted financing, future costs of exploration programs, timing of activities, future oil and gas prices, amongst other things. Such estimates are subject to uncertainty and should our estimates be materially incorrect, the Company's ability to continue as a going concern would be impaired and these consolidated financial statements could require material adjustments to the value of assets and liabilities. These consolidated financial statements do not reflect any such adjustments or reclassifications.
Subsequent to December 31, 2012, the Company entered into share purchase agreement with Sarus Energy Limited, sold its office premise in India and entered into agreement with a private Israeli investment group. Proceeds received from these transactions will be used to reduce the working capital deficiency. As of today, these transactions, except for sale of office premise in India, have not closed and there can be no certainty that these transactions will successfully close. The Company's ability to continue to meet our ongoing financial commitments and pay our creditors is dependent on closing these transactions.
I stopped trading on TDA about 5 years ago when it was taking forever for my orders to go through even with the buy/sells adjusted so they would go through faster. I've been on E-Trade ever since and don't have near the problem with them that I had with TDA.
No, not yet.
Here are the e-mail addresses of Dr. King ( MRK93@cornell.edu )and James Wemett ( info@naturalnano.com ), maybe you can get a reply from either of them about whats going on at this one man operation.
Time to break out the Jim Beam Black this morning, this is going to be another disappointing day as their stock price goes down, down, down...
GGR's price/book ratio is .1670, the lowest price/book field in the industry.
Bloomberg has GeoGlobal Resources listed as having an earnings announcement today, let's hope so and they have positive earnings to report.
The problem is I can't afford to turn the lights on after purchasing this stock.
Thanks.
Does anyone know when the merger will be final and has anybody heard what the new stock symbol will be.
Only good PR's coming out from this company will be full of lies.
I believe his target price is if you're going long for a few years.
They've received 2 mil. and waiting for the India government to approve everything and then they'll get the remaining 14 mil.
Good morning boys and girls.
Good morning boys and girls.
Good morning boys and girls.
I've sent an e-mail to Dr. King and Mr. Wemett about two weeks ago, neither sent me a reply. I don't have much faith in a one man operation, who would give a contract to a company like that and expect to get your product in the time frame they need it.
Lack of revenue, they're restructuring the company and if the NYSE approved their plan back in Feb. to keep trading on the NYSE, it must have some credibility. Between now and May 31 will be interesting and when they get approved in India the stock will easily hit .10
When India approves the sale of their assets there, they will get the remaining 14 mil owed and the price will hit double digits IMO.
I might be dumping 830K shares tomorrow so it might drop on you all. I don't see any future in this one man company.
Symbol GGR
Last Trade
15:59 09 Apr
Change Volume
GGR $ 0.04 +0.01 (+44.44%) 8,840,591
Website: http://www.geoglobal.com/
Today's
Open High Low
0.03 0.05 0.03
Previous Day's
Close NYSE Only Close
0.03 0.03
52 Week
High Low
0.49 0.03
27 Jun 2012 08 Apr 2013
P/E Ratio -0.12
Indicated Annual Dividend 0.00
Beta Coefficient 2.13
Earnings per Share -0.22
Yield (%) 0.00
Market Cap (billion) 0.01 B
Shares Outstanding 185,900,000
I don't know where you're getting your information but they're on the NYSE.
They trade on the NYSE, not OTC. You might need to study your charts a little better before leaving all these incorrect comments.
Up 15% to .045 in after hour trading
Todays PR
GeoGlobal Resources Inc. ("GeoGlobal" or the "Company") (NYSE MKT: GGR) announced today that it has entered into a share purchase agreement with Sarus Energy Ltd. ("Sarus") pursuant to which Sarus will acquire 100% of the issued and outstanding shares of a wholly owned subsidiary of the Company, GeoGlobal Exploration (Barbados) Inc. ("GEB"), in a two-part transaction.
Included in the transaction is the Company's 14% - 20% participating interest ("PI") in the CB-ON/2 PSC ("Tarapur"), which includes: the Tarapur Mining Lease and the Tarapur Ring Fenced PSC; a 10% PI in CB-ONN-2003/2 ("Ankleshwar"); and a 10% PI in CB-ONN-2002/3 ("Sanand/Miroli"), (collectively referred to as the "Cambay Assets").
On the first closing date, Sarus will acquire 49% of the issued and outstanding shares of GEB for US$2,000,000. The first part of the transaction is expected to close on April 12, 2013.
On the second closing date, Sarus will acquire the remaining 51% of the shares of GEB for US$14,000,000. The second closing is subject to certain terms, conditions and consents, including the approval of the Government of India.
They've only 250,000,000 authorized common stock
They've 138,343,051 shares outstanding if you bothered to look at their website.
I've 630K shares, is it time for me to dump and just move on?
Does someone know why E-Trade shows a Market Cap of 5.08 M and on this site it says the Market Cap is 4.3 M?
I was able to find some research information on Cornell University website about Halloysite Nanotubes that NaturalNano says it uses, the study was by Dr. King that was in a video put out by NaturalNano.
www.cctec.cornell.edu
Inventors:
Michael King
Xiaoyan Yin
Kuldeepsinh Rana
Varun Ponmudi
Andrew Hughes
Patents:
Filed
Contact:
Jeff Fearn, PhD
Sr. TCLO
Office: 607
Functionalized Liposomes for Targeting and Treatment of Diseases
Invention Summary:
Several technologies in combination create a novel method to target and/or treat cells, such as metastasized cancer cells. This invention involves the use of functionalized liposomes. These liposomes may be functionalized with an adhesion molecule such as selection alone or in combination with other entities. These liposomes may also have incorporated within it molecules such as iRNA or drugs. Cornell researchers have shown proof of principle by functionalizing the surface of the liposome with selection, which can interact with certain cancer cells. These liposomes can also have incorporated on their surface or into them.
1.FUT3 siRNA
functions by decreasing protein expression of fucosyltransferase 3 of cancer cells, thus inhibiting metastasis.
2.Doxorubicin
a cancer-killing agent that directly destroys cancer cells.
3. TRAIL–interacts with the Death Receptor on cancer cells, initiating their death.
Cornell inventors have also used functionalized halloysite anotubes that project from the surface of the microtube they coat, increasing the available surface area and thus significantly enhancing the capture of circulating tumor cells and binding them. There is no effect on the viability of these cells, enabling their use for in vitro studies on the characteristics of the cancer and experimental drug therapies.Background Information: Most cancer- related deaths are associated with the formation of metastatic tumors. One problem with targeted drug delivery to cancer cells is that the cancer cells have similarities with some normal cells, and are thus compromised during the course of treatment. A more targeted approach is needed to preserve the integrity of normal, healthy human cells while inducing apoptosis in cancer cells that have metastasized.
Office of the Vice Provost for Technology
Transfer and Economic Development
Technical Merits: Liposomes may be adapted to different cancers by functionalizing with the appropriate binding molecule, or to other sites, such as areas of inflammation.Functionalized liposomes can be used alone or in conjunction with other therapies.Halloysite nanotubes increase surface area by projecting from surface. Potential to use these novel therapies in vivo. Potential Commercial applications:
Treatment of metastasized cancer using FUT3 siRNA.
Treatment of other cancers, inflammation and other targets.
Screening tool for drug therapies
Research tool Potential Advantages
Metastasized CTCs are specifically targeted without harm to normal cells. Can functionalize liposomes to specifically target cell of interest. With halloysite nanotubes, the viability of CTCs is preserved, enabling the cells to be cultured in vitro for determination of cancer characteristics and testing drug therapies.
This is the most recent SEC filing I can find.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
February 21, 2013
(Date of earliest event reported)
GRAPHIC
GEOGLOBAL RESOURCES INC.
(Exact name of Registrant as specified in its Charter)
Delaware
(State or other jurisdiction of
incorporation or organization)
1-32158
(Commission File
Number)
33-0464753
(I.R.S. Employer
Identification No.)
200, 625 – 4 th Avenue SW
Calgary, Alberta, Canada T2P 0K2
(Address of principal executive offices)
Telephone Number (403) 777-9250
(Registrant's telephone number, including area code)
(Former name or address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
On February 21, 2013, GeoGlobal Resources Inc. (the “Company”) issued a press release announcing that the NYSE MKT LLC notified the Company that it accepted the Company’s Plan of compliance and granted the Company an extension until May 31, 2013 to regain compliance with the continued listing standards.
The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
Exhibits.
99.1
Press Release, dated February 21, 2013.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: February 21, 2013
GEOGLOBAL RESOURCES INC.
(Registrant)
/s/ Patti J. Price
Patti J. Price
Secretary
Thanks.
Can someone tell me the reason why after I Searched the New York corporation registry, that NaturalNano is not ever been on file past or present?